The Neurological Health Engine

Predict.

Engage.

Cure.

Redefining neurological care
with AI-powered precision,
clinician collaboration, and
scalable health solutions.

1.1 Billion Sufferers.

80% Misdiagnosed.

$8M/Day Lost.

  • 1.1B people globally suffer from neurological disorders (IHME).

  • 50–80% of headache patients are misdiagnosed (Patient Care Online).

  • Pharma loses $8M/day due to diagnostic delays (JAMA, 2021).

  • 276M healthy life years lost annually (DALYs, IHME).


AI + Clinicians = 92% Accuracy.

92% accuracy via
wearables, symptom
diaries, and weather
data.

5-Day Headache
Forecast

$25k/patient referral fees for pharma partners (validated by MVP).


Clinical Trial Accelerator

Real-time clinician review
(<2 mins) via
integrated
dashboard.

Clinician-Validated AI

Only platform with
clinician-in-loop
validation.

Predict

Track

Validate

Match

$200B Predictive

Neurology Market.

200B/21B / $2.1B.

TAM/SAM/SOM:

$12.8B market, 8.9% CAGR to
2030 (Grand View Research).

Neurology Devices:

20% annual growth
(Fortune Business I
nsights).

Telemedicine:

$80.7B market, 6.5% CAGR to
2030 (Grand View Re
search).

Clinical Trials:

95% clinician satisfaction (Clinical Center
Niš pilot).

Patients engage 4x/week (vs. 1.3x industry
average).

12.5M/yearpharmarevenuepotential(500pa
tients×25k).

Advanced negotiations with 3 CRO
partners.


The Neurological Health Engine

Proven.

Scalable.

Investor-Ready.

B2C: $19.99/month (patients).

CRO-Pharma: $25k/patient referral

B2B: $299/month (clinics).

Triple Revenue
Streams. 87% Gross
Margins.

Margins: 87% (AWS + clinician
workflow automation).


Backed by Experts.

Built to Scale.

Nemanja Stamenović (Co-Founder, AI Lead): Ex-PubMed &
WoltersKluwer ML models.

Miloš Vidojković (Co-Founder, Architect): 12+ years scaling
enterprise platforms.

Advisors: Neurologists & Professors, Clinical Center Niš

Own a Stake in the $200B
Neuro Revolution.

  • Pre-Seed Ask: $1M for 12-month runway (5,000 users, 20 clinics).

  • Milestone: $200M valuation by Series A (2025).

  • Vision: Dementia agent (2025), Epilepsy & Parkinson’s (2026), IPO/exit (2027).


Phone Number

Email Address

info@empedoc.com

+381 64 35 553 15

Let’s
Transform
Neurology.
Together.

© 2025 EmpedocAI. All rights reserved.

Privacy Policy | Terms of Service


Backed by Clinical Center Niš Neurologists